Kenkare-Mitra Sara
CIK 0001895592
President and Head of R&DDirector
Filings
19
Latest May 21, 2026
Issuers covered
2
Showing
19 of 19
Page 1
Track record
12 of 12 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 12 | 58% | -0.6% | +11.5% | +24.7% | -36.8% |
| 90 days | 12 | 67% | +0.6% | +7.9% | +52.5% | -87.7% |
| 180 days | 12 | 75% | +7.2% | +19.2% | +70.1% | -83.9% |
| 365 days | 10 | 80% | +26.0% | +35.1% | +79.1% | -49.6% |
Issuers
Companies where Kenkare-Mitra Sara has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ALEC | Alector, Inc. | 16 | Dec 3, 2025 |
| UNCY | Unicycive Therapeutics, Inc. | 3 | May 21, 2026 |
All filings
19 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|